Newborn dried blood-spot screening of the p.V37I variant of GJB2 by high-resolution melting analysis.
To establish a high-throughput, low-cost method for neonatal genetic testing of the p.V37I of GJB2 gene, which is highly prevalent in East Asians and strongly associated with postnatal childhood hearing impairment. A total of 6460 newborn blood-spot DNA samples were screened by high-resolution melting analysis (HRMA). The screening results were further verified by direct sequencing of 28 homozygous, 545 heterozygous and 200 wild-type samples. Our study indicated that the HRMA-based bloodspot screening method was of very high sensitivity and specificity and was suitable for large-scale screening of the p.V37I variants in newborns.